Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair
Author(s) -
Malte Tiburcy,
James E. Hudson,
Paul Balfanz,
Susanne F. Schlick,
Tim Meyer,
Mei-Ling Chang Liao,
Elif Levent,
Farah Raad,
Sebastian Zeidler,
Edgar Wingender,
Johannes Riegler,
Mouer Wang,
Joseph Gold,
Izhak Kehat,
Erich Wettwer,
Ursula Ravens,
Pieterjan Dierickx,
Linda W. van Laake,
MarieJosé Goumans,
Sara Khadjeh,
Karl Toischer,
Gerd Hasenfuß,
Larry A. Couture,
Andreas Unger,
Wolfgang A. Linke,
Toshiyuki Araki,
Benjamin G. Neel,
Gordon Keller,
Lior Gepstein,
Joseph C. Wu,
WolframHubertus Zimmermann
Publication year - 2017
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.116.024145
Subject(s) - induced pluripotent stem cell , heart failure , embryonic stem cell , medicine , myocyte , microbiology and biotechnology , inotrope , stem cell , biology , biochemistry , gene
Advancing structural and functional maturation of stem cell-derived cardiomyocytes remains a key challenge for applications in disease modeling, drug screening, and heart repair. Here, we sought to advance cardiomyocyte maturation in engineered human myocardium (EHM) toward an adult phenotype under defined conditions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom